IM
Immunotech Laboratories, Inc.
IMMB · OTC
$0.00 +0.00% (+$0.00)
Market Cap ¥406.6K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
56 /100
Fair P/E 0.00x
PEG 2.56x
EV/EBITDA 14.92x
Growth
39 /100
Stable Rev. growth 8.56%
Book val. growth 0.17%
FCF growth 87.87%
Profitability
8 /100
Weak Gross margin 3.15%
Op. margin 2.21%
Net margin 1.15%
Quality
36 /100
Average ROIC 3.51%
Asset turnover 1.54x
ROA 1.76%
Debt
16 /100
High Debt/Equity 2.56x
Net debt/EBITDA 14.92x
Current ratio 1.24x
Stability
40 /100
Moderate Beta -5.14x
Profitable years 1
Rev. volatility 12.56%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na IMMB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer L. Bath
Employees
4
Headquarters
Monrovia